🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniela Ramos

ORCID: 0000-0002-8940-0232

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma”.

A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2566

N/A

1.3DataRank · unranked

43 citations

Hee-Jin Jang, Maheshwari Ramineni, Daniel Wang, Daniela Ramos, Jong Min Choi +10 more

Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant Mesothelioma

The Annals of Thoracic Surgery(2021)10.1016/j.athoracsur.2021.08.054

N/A

0DataRank · unranked

29 citations

Cynthia Truong, Eric Lo, Hudson M. Holmes, Daniela Ramos, Maheshwari Ramineni +7 more

Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment

Cancer Research(2022)10.1158/0008-5472.can-21-3506

N/A

0DataRank · unranked

16 citations

Hyun‐Sung Lee, Wendong Yu, Maheshwari Ramineni, Cynthia Truong, Daniela Ramos +13 more

Data from Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment

(2023)10.1158/0008-5472.c.6514119.v1

N/A

0DataRank · unranked

0 citations

Hyun‐Sung Lee, Wendong Yu, Maheshwari Ramineni, Cynthia Truong, Daniela Ramos +13 more